Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Neurology and Therapy|October 22, 2020
Immunomagnetic Reduction Detects Plasma Aβ1-42 Levels as a Potential Dominant Indicator Predicting Cognitive DeclineShieh-Yueh Yang, Huei-Chun Liu, Wen-Ping ChenDementia and Geriatric Cognitive Disorders Extra|April 21, 2020
Stability of Plasma Amyloid-β 1-40, Amyloid-β 1-42, and Total Tau Protein over Repeated Freeze/Thaw CyclesHuei-Chun Liu, Ming-Jang Chiu, Chin-Hsien Lin, et al.Neurobiology of Disease|December 27, 2012
Decreased stathmin expression ameliorates neuromuscular defects but fails to prolong survival in a mouse model of spinal muscular atrophyHsin-Lan Wen, Chen-Hung Ting, Huei-Chun Liu, et al.Proteomics|July 27, 2004
Antioxidant role of human haptoglobinChi Feng Tseng, Chia Ching Lin, Hsing Yi Huang, et al.RSC Advances|July 3, 2026
Immunomagnetic reduction detects amyloid β 1-42, but neither x-42 nor 1-yHuei-Chun Liu, Chin-Yi Lin, Chia-Shin Ho, et al.ACS Omega|July 3, 2026
Changes in Plasma Amyloid β 1-42 Peptide and Total Tau Protein from Normal Cognition to Sever-Stage Alzheimer's Disease Using an Immunomagnetic Reduction AssayShieh-Yueh Yang, Huei-Chun Liu, Ming-Jang Chiu, et al.Plos One|June 13, 2020
Development of an assay of plasma neurofilament light chain utilizing immunomagnetic reduction technologyHuei-Chun Liu, Wei-Che Lin, Ming-Jang Chiu, et al.Journal of Clinical Medicine|October 19, 2019
Plasma pS129-α-Synuclein Is a Surrogate Biofluid Marker of Motor Severity and Progression in Parkinson's DiseaseChin-Hsien Lin, Huei-Chun Liu, Shieh-Yueh Yang, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 5, 2020
Plasma pyroglutamate-modified amyloid beta differentiates amyloid pathologyPei-Ning Wang, Kun-Ju Lin, Huei-Chun Liu, et al.Dementia and Geriatric Cognitive Disorders|August 14, 2020
Effect of Times to Blood Processing on the Stability of Blood Proteins Associated with DementiaJui-Feng Chang, Huei-Chun Liu, H H Chen, et al.Pageof 2